Clinical Trials on Intestinal Permeability
Total 0 results
Nothing found
Sponsors and Collaborators
- Freeline Therapeutics
- Peter Daley
- Mellitor
- University Teaching Hospital, Lusaka, Zambia
- RTI Surgical Inc.
- Taitung Mackay Memorial Hospital
- Fundacion de la Sociedad Chilena de Cardiologia y Cirugia Cardiovascular
- Okayama University
- Elif Oral
- Manusapiens
- Laura Esserman
- St. Louis Children's Hospital
- Klinbeforsk
- SARA and Linkages Projects, Academy for Educational Development, Washington DC.
- Carl T. Hayden VA Medical Center
- 3ive Labs
- Uri Elchalal
- Conseil National des Exploitants Thermaux
- Narodowy Instytut Zdrowia Publicznego
- Hospital of Roubaix
- View Full List
Medical Conditions
- Refractory B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma
- 25-hydroxyvitamin D Concentration (Vitamin D Status)
- No Severe Congenital Anomalies
- Hypogonadotrophic Hypogonadism
- Major Depressive Disorder With Mixed Features
- Unresected Stage IIIb to IVM1c Melanoma
- Stage IVA Adenocarcinoma of the Gastroesophageal Junction
- Catheter Related Complication
- Tendon Rupture - Shoulder
- Elevated Intracranial Pressure (ICP)
- Bio-availability of Wheat Bran Phytochemicals in the Human Gut
- Non-relaxing Puborectalis Syndrome
- Ewing Sarcoma, Recurrent, Refractory
- Obstetric Surgical Procedures
- Volume Deficiency in the Mid-Face
- Resorption of Bone Graft
- Profound Bilateral Hearing Loss
- Age-related Maculopathy
- Cerebral Palsy, Autism or Other Neuromotor Behavior Abnormalities Correlation With Anthropometry
- Accuracy of Surgical Guide in Computer Guided Implantology
- View Full List
Drug Interventions
- RO5271983 - SAD
- Levobupivacaine
- PUR118
- Dexamethasone
- New trio de Kligman
- 2% urea/20% glycerol cream
- GLPG1972 - C
- Lisinopril 40 mg Tablet under fasting conditions.
- TQ-B3525
- Penicillins
- BL-M07D1
- Tranexamic Acid
- Chewable Tablet
- Everolimus
- Amoxicillin Clavulanate
- Morphine
- Fimasartan (BR-A-657•K) 60 mg
- Hydroxychloroquine
- Elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide or bictegravir/emtricitabine/tenofovir alafenamide or other medically-appropriate FDA-approved antiretroviral therapy
- Low sodium high potassium salt substitute
- View Full List
CROs by country
- Contract Research Organizations in Bosnia & Herzegovina
- Contract Research Organizations in Burundi
- Contract Research Organizations in Cote d'Ivoire
- Contract Research Organizations in Ecuador
- Contract Research Organizations in Egypt
- Contract Research Organizations in Germany
- Contract Research Organizations in Guinea
- Contract Research Organizations in Latvia
- Contract Research Organizations in Liberia
- Contract Research Organizations in Mozambique
- Contract Research Organizations in Romania
- Contract Research Organizations in Switzerland
- Contract Research Organizations in Taiwan
- CRO list by country